Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Shares Outstanding (Weighted Average): 2011-2025

Historic Shares Outstanding (Weighted Average) for Abeona Therapeutics (ABEO) over the last 15 years, with Sep 2025 value amounting to $51.3 million.

  • Abeona Therapeutics' Shares Outstanding (Weighted Average) rose 18.39% to $51.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.3 million, marking a year-over-year increase of 18.39%. This contributed to the annual value of $43.5 million for FY2024, which is 75.48% up from last year.
  • As of Q3 2025, Abeona Therapeutics' Shares Outstanding (Weighted Average) stood at $51.3 million, which was up 0.24% from $51.2 million recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $51.3 million for Q3 2025, and its period low was $4.0 million during Q1 2021.
  • Over the past 3 years, Abeona Therapeutics' median Shares Outstanding (Weighted Average) value was $41.2 million (recorded in 2024), while the average stood at $35.7 million.
  • Data for Abeona Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 321.31% (in 2022) over the last 5 years.
  • Over the past 5 years, Abeona Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $4.1 million in 2021, then skyrocketed by 321.31% to $17.2 million in 2022, then skyrocketed by 44.23% to $24.8 million in 2023, then skyrocketed by 75.48% to $43.5 million in 2024, then grew by 18.39% to $51.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $51.3 million in Q3 2025, compared to $51.2 million in Q2 2025 and $48.5 million in Q1 2025.